Oral Presentation 49th Annual Scientific Meeting of the Australian and New Zealand Society for Immunology 2021

Unique Evolution of Antiviral Tetherin in Bats (#54)

Joshua Hayward 1 2 , Mary Tachedjian 3 , Adam Johnson 1 , Aaron T Irving 4 5 6 , Tamsin B Gordon 1 2 , Jie Cui 7 8 , Alexis Nicolas 3 , Ina Smith 3 , Vicky Boyd 9 , Glenn A Marsh 3 , Michelle L Baker 3 , Linfa Wang 6 10 11 , Gilda Tachedjian 1 2 10
  1. Retroviral Biology and Antivirals Laboratory, Life Sciences Discipline, Disease Elimination Program, Burnet Institute, Melbourne, VIC, Australia
  2. Department of Microbiology, Monash University, Melbourne, VIC, Australia
  3. Australian Centre for Disease Preparedness, CSIRO, Geelong, VIC, Australia
  4. University of Edinburgh Institute, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
  5. Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University, Hangzhou, China
  6. Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore
  7. CAS Key Laboratory of Molecular Virology & Immunology, Institut Pasteur of Shanghai, Shanghai, China
  8. Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, China
  9. Australian Centre for Disease Preparedness, Commonwealth Scientific and Industrial Reseach Organisation, Geelong, VIC, Australia
  10. Department of Microbiology and Immunology at the Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia
  11. Singhealth Duke-NUS Global Health Institute, Duke-NUS, Singapore

Bats are recognised as important reservoirs of viruses deadly to other mammals, including humans.  These infections are typically nonpathogenic in bats raising questions about host response differences that might exist between bats and other mammals.  Tetherin is a restriction factor which inhibits the release of a diverse range of viruses from host cells, including retroviruses, coronaviruses, filoviruses, and paramyxoviruses, some of which are deadly to humans and transmitted by bats. Here we characterise the tetherin genes from 27 species of bats, revealing that they have evolved under strong selective pressure, and that fruit bats and vesper bats express unique structural variants of the tetherin protein. Tetherin was widely and variably expressed across fruit bat tissue-types and upregulated in spleen tissue when stimulated with Toll-like receptor agonists. The expression of two computationally predicted splice isoforms of fruit bat tetherin was verified.  We identified an additional third unique splice isoform which includes a C-terminal region that is not homologous to known mammalian tetherin variants but was functionally capable of restricting the release of filoviral particles. We also report that vesper bats possess and express at least five tetherin genes, including structural variants, a greater number than any other mammal reported to date. These findings support the hypothesis of differential antiviral gene evolution in bats relative to other mammals.